Automated Multi-Patient CT Injection System Reduces Patient Set-Up Time and Streamlines Workflows

Consequently, radiology technologists are required to work more efficiently and quickly, all while upholding the highest safety standards. In response to this challenge, a multi-patient CT injection system is designed to meet the increasing demand for solutions that simplify, improve, and streamline workflows in radiology departments.

Bayer’s (Leverkusen, Germany) MEDRAD Centargo CT injection system is a cutting-edge multi-patient injector designed to enhance workflow efficiency, particularly in high-volume CT suites. The system streamlines the setup process, enabling the multi-patient configuration to be completed in under two minutes using the pre-assembled Day Set. The snap-in patient line auto-primes when inserted and is ready for the next patient in less than 20 seconds. Data entry is simplified through an integrated barcode reader, which allows easy access to contrast and injection details, especially when used with Automated Documentation software.

This advanced contrast injection system features piston-based technology, allowing for Dual Flow—simultaneous delivery of contrast and saline—providing greater flexibility for demanding protocols. The system also includes two check valves in the patient line to reduce the risk of cross-contamination, and air removal technology ensures efficient inlet and outlet air detection. This design helps radiology technologists focus more on patient care by minimizing administrative and procedural burdens, particularly in high-throughput environments. When integrated with Bayer’s imaging and workflow solutions, the system enhances contrast usage and facilitates connectivity to the modality worklist and scanner. Bayer has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the MEDRAD Centargo CT injection system, offering valuable support to radiology departments in the U.S. that are facing a shortage of technologists and an increasing demand for medical imaging.

“Since its launch in 2020, Centargo has served approximately seven million patients across 49 markets worldwide. The FDA clearance further demonstrates our nearly 40 years of CT innovation and commitment to delivering effective technologies to improve diagnostic imaging for patients,” said Sven Schmidt, Head of Region Americas Radiology at Bayer. “We know radiologists today are facing a continuously increasing workload, and the automation, integration and mobility of the MEDRAD Centargo CT Injection System helps radiology staff do more with less, allowing them more time to focus on their patients.”